Main
ENG
  • ITA

Commitment to innovation.

New company in LabAnalysis Group: LabAnalysis Process Pharma

LLabAnalysis Group ends the year by expanding the family, welcoming the newly formed LabAnalysis Process Pharma (LPP) with open arms. The new company represents an important integration in group perspective, especially in the following aspects of the pharmaceutical world:

Process Validation 
Filter Validation & Single Use Technology
Material Qualification

LabAnalysis Process Pharma was established to provide high-quality analytical and validation services in accordance with the latest GMP regulations, using a team of experienced Project Managers and laboratory technicians, with state-of-the-art equipment at their disposal.

The expertise of the Project Managers, who have been active in the field for years, allows them to assist the client throughout the entire validation project, from the definition of the study protocol and its design to the final discussion of the results with regulatory authorities. In addition, LPP's laboratories are fully equipped for any type of validation and process development activities (e.g., filtration systems, single-use components and systems, qualification of primary packaging and all materials involved in the production process).

Additional strength is definitely the synergy with LabAnalysis Group companies, which expands the portfolio of services, allowing greater scope of analytical activities for validation, quality control, investigation (OOS) and testing.

While specializing in the validation of aseptic processes for the production of sterile pharmaceutical products and the qualification of materials in direct and indirect contact with the formulated pharmaceutical product, LPP also offers assistance with validation studies and consulting for nonsterile, cosmetic and medical device processes.

The first steps have already been taken, with participation in CPhI Frankfurt 2022 as a representative arena for an international market to be professionally supported. From here on, a path of growth is envisaged, with attention to the latest technical and regulatory innovations, from the perspective of a group committed to innovation.

For more information you can visit the web showcase labprocesspharma.it or email processpharma@labanalysis.it